Pain Relief and Functional Outcome After Partial Denervation of the Wrist

March 28, 2022 updated by: Elin Swärd, Karolinska Institutet

A Prospective Study on Pain Relief and Functional Outcome After Partial Denervation of the Wrist

Prospective study on the effect of partial wrist denervation (ie combined anterior and posterior interosseous neurectomy) on pain relief on functional outcome in patient with wrist osteoarthritis. The impact of psychological factors on postoperative outcome will be studied.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Stockholm, Sweden, 11883
        • Handkirurgiska kliniken Södersjukhuset

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria

  1. Chronic wrist pain (≥6 months) due to posttraumatic arthritis after distal radius fracture or SLAC/SNAC arthritis or arthritis due to Mb Preiser/Mb Kienböck where surgical unloading of the bone isn't possible.
  2. Pain is refractory to nonsurgical management such as bracing, corticosteroid injection, oral analgesics, NSAIDs, physiotherapy.

Exclusion criteria

  1. Rheumatoid or other inflammatory arthritis.
  2. Previous wrist surgery with simultaneous PIN/AIN neurectomy.
  3. Simultaneous arthritis or symptomatic instability of the distal radio ulnar (DRU) joint on the ipsilateral side.
  4. Inability to co-operate with the follow-up protocol (language difficulties, severe psychiatric disorder, cognitive impairment, drug addiction).
  5. Patient's wish for a definite procedure.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Partial denervation of the wrist joint
Patients will be operated with a partial denervation of the wrist through a single dorsal approach.
Partial denervation of the wrist (posterior and anterior interosseous neurectomy) through a single dorsal approach.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Disability of the Arm, Shoulder and Hand score (DASH)
Time Frame: peroperatively, 3, 6 and 12 months postoperatively
questionnaire
peroperatively, 3, 6 and 12 months postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Patient Related Wrist Evaluation (PRWE)
Time Frame: peroperatively, 3, 6 and 12 months postoperatively
questionnaire
peroperatively, 3, 6 and 12 months postoperatively
Change in EQ5D
Time Frame: peroperatively, 3, 6 and 12 months postoperatively
questionnaire
peroperatively, 3, 6 and 12 months postoperatively
Change in Hospital Anxiety and Depression Scale (HADS)
Time Frame: peroperatively, 3, 6 and 12 months postoperatively
questionnaire. Determines the levels of anxiety and depression. 14 item scale that generates ordinal data. Seven items relate to anxiety and seven to depression. Each item is scored from 0-3, which means that a person can score between 0-21 for either depression or anxiety. A score of 11 or above on either scale in considered to repressent depression or anxiety.
peroperatively, 3, 6 and 12 months postoperatively
Change in range of motion, grip strength
Time Frame: peroperatively, 3, 6 and 12 months postoperatively
objective physical function
peroperatively, 3, 6 and 12 months postoperatively
Change in Sence Of Coherence -13 (SOC13)
Time Frame: peroperatively, 3, 6 and 12 months postoperatively
Questionnaire
peroperatively, 3, 6 and 12 months postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Maria Wilcke, MD, PhD, Karolinska Institutet

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 31, 2017

Primary Completion (Actual)

August 31, 2021

Study Completion (Actual)

August 31, 2021

Study Registration Dates

First Submitted

December 13, 2017

First Submitted That Met QC Criteria

December 18, 2017

First Posted (Actual)

December 19, 2017

Study Record Updates

Last Update Posted (Actual)

March 31, 2022

Last Update Submitted That Met QC Criteria

March 28, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Karolinska Institute

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Wrist Arthritis

Clinical Trials on Partial denervation of the wrist joint

3
Subscribe